研究業績 2014年

  • Sakiyama M, Matsuo H, Takada Y, Nakamura T, Nakayama A, Takada T, Kitajiri SI, Wakai K, Suzuki H, Shinomiya N. Ethnic Differences in ATP-binding Cassette Transporter, Sub-Family G, Member 2 (ABCG2/BCRP): Genotype Combinations and Estimated Functions. Drug Metab Pharmacokinet. 2014 Dec 25;29(6):490-2. [abstract]
  • Sakiyama M, Matsuo H, Shimizu S, Nakashima H, Nakayama A, Chiba T, Naito M, Takada T, Suzuki H, Hamajima N, Ichida K, Shimizu T, Shinomiya N. A Common Variant of Organic Anion Transporter 4 (OAT4/SLC22A11) Gene Is Associated with Renal Underexcretion Type Gout. Drug Metab Pharmacokinet. 2014 Apr 25;29(2):208-10.[abstract]
  • Sakiyama M, Matsuo H, Shimizu S, Chiba T, Nakayama A, Takada Y, Nakamura T, Takada T, Morita E, Naito M, Wakai K, Inoue H, Tatsukawa S, Sato J, Shimono K, Makino T, Satoh T, Suzuki H, Kanai Y, Hamajima N, Sakurai Y, Ichida K, Shimizu T, Shinomiya N. A common variant of leucine-rich repeat-containing 16A (LRRC16A) gene is associated with gout susceptibility. Hum Cell. 2014 Jan;27(1):1-4. [abstract]
  • Ohno Y, Yamada M, Yamaguchi R, Hisaka A, Suzuki H. Persistent drug interaction between aprepitant and warfarin in patients receiving anticancer chemotherapy. Int J Clin Pharm. 2014 Dec:36(6):1134-7. [abstract]
  • Ito N, Ito K, Ikebuchi Y, Kito T, Miyata H, Toyoda Y, Tappei T, Hisaka A, Honma M, Oka A, Kusuhara H, Suzuki H. Organic cation transporter/solute carrier family 22a is involved in drug transfer into milk in mice. J Pharm Sci. 2014 Oct;103(10):3342-8. [abstract]
  • Hisaka A, Nakamura M, Tsukihashi A, Koh S, Suzuki H.  Assessment of Intestinal Availability (FG) of Substrate Drugs of Cytochrome P450s by Analyzing Changes in Pharmacokinetic Properties Caused by Drug-Drug Interactions. Drug Metab Dispos. 2014 Oct;42(10):1640-5. [abstract]
  • Abe T, Yanagihara Y, Uchino T, Oriyama T, Komatsu M, Nakajima K, Suzuki H. Evaluation of the Pharmaceutical Characteristics of Various Enteric-Coated Aspirin Tablets under Different Storage Conditions. Chem Pharm Bull. 2014 62(7) 617–626. [abstract]
  • Nakayama A, Matsuo H, Nakaoka H, Nakamura T, Nakashima H, Takada Y, Oikawa Y, Takada T, Sakiyama M, Shimizu S, Kawamura Y, Chiba T, Abe J, Wakai K, Kawai S, Okada R, Tamura T, Shichijo Y, Akashi A, Suzuki H, Hosoya T, Sakurai Y, Ichida K, Shinomiya N. Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors.  Sci Rep. 2014 Jun 9;4:5227. [abstract] [プレスリリース]

  • Panthee N, Ono M, Morota T, Tanaka T, Itoda Y, Ikemura M, Yamamoto T, Suzuki H, Saito A, Motomura N.  Paraplegia prevention by oral pretreatment with memantine in a rabbit model. J Thorac Cardiovasc Surg. 2014 Oct;148(4):1732-8. [abstract]

  • Suzuki S, Shuto T, Sato T, Kaneko M, Takada T, Suico MA, Cyr DM, Suzuki H, Kai H. Inhibition of post-translational N-glycosylation by HRD1 that controls the fate of ABCG5/8 transporter.  Sci Rep. 2014 Mar 3;4:4258 [abstract]

  • Honma M, Ikebuchi Y, Kariya Y, Suzuki H. Regulatory Mechanisms of RANKL Presentation to Osteoclast Precursors. Curr Osteoporos Rep. 2014 Mar;12(1):115-20. [abstract] 

  • Matsuo H, Nakayama A, Sakiyama M, Chiba T, Shimizu S, Kawamura Y, Nakashima H, Nakamura T, Takada Y, Oikawa Y, Takada T, Nakaoka H, Abe J, Inoue H, Wakai K, Kawai S, Guang Y, Nakagawa H, Ito T, Niwa K, Yamamoto K, Sakurai Y, Suzuki H, Hosoya T, Ichida K, Shimizu T, Shinomiya N. ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload.  Sci Rep. 2014 Jan 20;4:3755. [abstract] [プレスリリース]
  • Honma M, Ikebuchi Y, Kariya Y, Suzuki H. Establishment of optimized in vitro assay methods for evaluating osteocyte functions. J Bone Miner Metab. 2015 Jan;33(1):73-84.  [abstract]